CEO SUMMARY: Pathology groups have a much better opportunity to turn the tables on payers and other third parties during contract negotiations if they come armed with the data and other information recommended by two well-respected pathology experts. In this final installment of our four-part series, the price transparency approach is explained. Also discussed is […]
Role of Price Transparency During Path Contract Talks
Savvy approaches to negotiate higher reimbursement from third parties
- By Robert Michel
- > From the Volume XXXII, No. 5 - March 31, 2025 Issue
- Tags: 88305, Al Sirmon, anatomic pathology groups, cpt code, executive war college, fee transparency, lab intelligence, Medicare Utilization Database, P and L, Panel of National Pathology Leaders, Part A Pathology Compensation Agreement, pathologist compensation, Pathology Practice Advisors, PNPL, Price transparency, profit and loss statement, Quicken, Robert Tessier MPH, UHC, UnitedHealthcare
